help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Knip, M.
Right arrow Articles by Koivisto, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Knip, M.
Right arrow Articles by Koivisto, M.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Medline Plus Health Information
*Diabetes and Pregnancy
*Diabetes Type 1
*High Risk Pregnancy
Hazardous Substances DB
*GLUCAGON

Journal of Clinical Endocrinology & Metabolism, Vol 77, 1340-1344, Copyright © 1993 by Endocrine Society


ARTICLES

Hormonal enteroinsular axis in newborn infants of insulin-treated diabetic mothers

M Knip, P Kaapa and M Koivisto
Department of Pediatrics, University of Oulu, Finland.

To study whether the increased glucose levels in the amniotic fluid during diabetic pregnancies induce an early maturation of the hormonal enteroinsular axis, we measured blood glucose levels and plasma concentrations of C-peptide, pancreatic glucagon, enteroglucagon, and gastric inhibitory polypeptide (GIP) in cord blood from 18 newborn infants of insulin-treated diabetic mothers (IDM) and 18 infants of nondiabetic mothers. In addition, we studied the same parameters in 20 IDM and 12 control infants before and after their first feed comprising human milk (5 mL/kg), given by nasogastric tube at the age of 2 h. The IDM had significantly higher blood glucose levels and plasma C-peptide concentrations in their cord blood than the control infants, which was followed postnatally by a substantial fall in these levels, whereas a more modest decrease could be seen in the control infants. Circulating enteroglucagon and GIP concentrations at the age of 2 h were significantly higher than those observed in cord blood in both the IDM and the control infants, but the IDM had significantly lower blood glucose levels, higher plasma C-peptide, and lower enteroglucagon concentrations before the first feed. There was a significant increase in blood glucose levels after the feed in both the IDM and the control infants, and the concentrations 2 h after feeding were of the same magnitude in the two groups. No significant C-peptide response could be observed in either group, but the IDM continuously had higher C-peptide concentrations. A significant enteroglucagon and GIP response could be seen in the IDM, whereas the controls exhibited only a GIP response. However, no significant differences were found between the two groups in the absolute postprandial plasma concentrations of these hormones. Our results show rapid, substantial postnatal changes in circulating concentrations of enteroinsular hormones in both IDM and control infants. Enteral feeding with human milk corrects early postnatal hypoglycemia within 2 h in most IDM without causing any exacerbation of their hyperinsulinemia. The absence of any C-peptide response to the first feed and of any observed differences between IDM and normal infants in absolute concentrations of enteroglucagon and GIP after the first feed suggests that the enteroinsular axis matures postnatally in both groups of infants.





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1993 by The Endocrine Society